🇺🇸 FDA
Pipeline program

METHOTREXATE, INFLIXIMAB, AZATHIOPRINE

Phase 3 small_molecule active

Quick answer

METHOTREXATE, INFLIXIMAB, AZATHIOPRINE for Immune system disorders is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Immune system disorders
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials